Stay Ahead in Fast-Growing Economies.
Browse Reports Now
Transdermal Drug Delivery Systems Market Trends, Analysis & Future Outlook (2024-2032)
The increasing incidence rate of diseases including chronic pain, cardiovascular diseases, and hormonal disorders will be a major growth point for transdermal drug delivery systems. Such systems bring improved drug effectiveness and dosage that are deemed beneficial by aging population of the world and patients on long-term prescriptions. Also, increased use of transdermal patches for patents such as nicotine replacement therapy as well as contraceptives also propels the market growth.
IMR Group
Description
Transdermal Drug Delivery Systems Market Synopsis:
Transdermal Drug Delivery Systems Market Size Was Valued at USD 33.60 Billion in 2023, and is Projected to Reach USD 53.93 Billion by 2032, Growing at a CAGR of 5.40% From 2024-2032.
Transdermal drug delivery systems refers to techniques and devices that help administer certain drugs via the outer layer of skin and directly into blood system bypassing the entire gastrointestinal system and regional blood circulation. Such systems are popular since they help to keep plasma drug concentrations constant, increase patients‘ compliance, and decrease GI adverse effects.
The increasing incidence rate of diseases including chronic pain, cardiovascular diseases, and hormonal disorders will be a major growth point for transdermal drug delivery systems. Such systems bring improved drug effectiveness and dosage that are deemed beneficial by aging population of the world and patients on long-term prescriptions. Also, increased use of transdermal patches for patents such as nicotine replacement therapy as well as contraceptives also propels the market growth.
Newer technologies of TDD like microneedle and iontophoresis are opening up pathways for delivering almost all types of drug molecules including the large molecule biologics. The global market is being fueled by the rising expenditure by pharma companies on research and development of transdermal technology along with approvals of advanced transdermal products by governmental health regulatory authorities.
Transdermal Drug Delivery Systems Market Trend Analysis:
The shift towards patient-centric drug delivery systems
Another trend is the changing in the focus to deliver drugs to the patient, and one of such innovations is transdermal system in a form of a patch. Transdermal systems are also changing to match the wearing and feedback abilities of healthcare devices with drug delivery technologies as they rise to meet the personalised medicine movement.
Conversely, advancements in biodegradable transdermal system are being pursued as a green solution to coatings in light of the medical waste issue that results from single use product. Some of these innovations in green production are expected to receive government backing, as well as signify customer pull in future years.
Increasing healthcare spending
The Transdermal drug delivery systems’ market has immense prospects in Asia-Pacific area because of the large population in the region, rising healthcare expenditure, as well as advances in the incidences of chronic diseases. Intensifying governmental and private concern for novel drug delivery methods in the emerging nations such as India and China gives more impetus to this market’s growth.
In addition, nanotechnology has been used in recent years to enhance transdermal systems and to expand the horizons of the delivery of macromolecules. Technologies like nanoparticle and liposome in patches for biologics and vaccines illustrate another set of opportunities that has not been fully realized in the sector.
Transdermal Drug Delivery Systems Market Segment Analysis:
Transdermal Drug Delivery Systems Market Segmented on the basis of Type, Application, End User, and Region.
By Type, Passive Transdermal Delivery Systems segment is expected to dominate the market during the forecast period
The Passive Transdermal Delivery Systems segment occupies the largest share because of its efficiency and versatility in uses such as smoking cessation mouthpiece and hormonal administration patch. These systems make use of diffusion and these are cheaper to implement. At the same time, Active Transdermal Delivery Systems, such as iontophoresis and microneedles, are becoming more popular as they allow delivering not only low molecular weight, but also peptides and proteins, which makes them suitable for precision medicine.
By Application, Pain Management segment expected to held the largest share
Pain Management is the largest segment amongst the different types of treatment, the increasing incidence of chronic diseases and the growing trend for less invasive procedures. With the growing demand for patch delivery systems for diseases like Parkinson’s disease and hormone replacement therapy, CNS Disorders and Hormonal disorders rank second and third respectively. Cardiovascular disorders and Others can be categorized as small but promising markets as transdermal systems begin their progression to bringing drugs for not only cardiovascular diseases but new therapeutic classes as well.
Transdermal Drug Delivery Systems Market Regional Insights:
North America is Expected to Dominate the Market Over the Forecast period
Currently, North America is the largest market for transdermal drug delivery systems due to factors such as enhanced healthcare facilities, high level of awareness and established key drug delivery manufacturers in that region. The increase in the incidence of chronic diseases, including diabetes and cardiovascular diseases, in the United States is stimulating the use of transdermal systems. Furthermore, regulatory approval for innovative products by heads of agencies such as the FDA has boosted the market’s growth in the region.
The essential application of transdermal systems in pain management along with a growing focus of North American companies on R&D consolidates the region’s lead. Furthermore, there is a positive reimbursement policy and high disposable income levels, which are the reasons behind the widespread use of the state-of-art drug delivery systems.
Active Key Players in the Transdermal Drug Delivery Systems Market:
3M Healthcare (USA)
Bayer AG (Germany)
Boehringer Ingelheim (Germany)
GlaxoSmithKline plc (UK)
Hisamitsu Pharmaceutical Co., Inc. (Japan)
Johnson & Johnson (USA)
Luye Pharma Group (China)
Mylan N.V. (USA)
Novartis AG (Switzerland)
Teva Pharmaceutical Industries Ltd. (Israel)
Other Active Players
Chapter 1: Introduction
1.1 Scope and Coverage
Chapter 2:Executive Summary
Chapter 3: Market Landscape
3.1 Market Dynamics
3.1.1 Drivers
3.1.2 Restraints
3.1.3 Opportunities
3.1.4 Challenges
3.2 Market Trend Analysis
3.3 PESTLE Analysis
3.4 Porter’s Five Forces Analysis
3.5 Industry Value Chain Analysis
3.6 Ecosystem
3.7 Regulatory Landscape
3.8 Price Trend Analysis
3.9 Patent Analysis
3.10 Technology Evolution
3.11 Investment Pockets
3.12 Import-Export Analysis
Chapter 4: Transdermal Drug Delivery Systems Market by Type
4.1 Transdermal Drug Delivery Systems Market Snapshot and Growth Engine
4.2 Transdermal Drug Delivery Systems Market Overview
4.3 Nitrocellulose Membranes
4.3.1 Introduction and Market Overview
4.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.3.3 Key Market Trends, Growth Factors and Opportunities
4.3.4 Nitrocellulose Membranes: Geographic Segmentation Analysis
4.4 PVDF Membranes
4.4.1 Introduction and Market Overview
4.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.4.3 Key Market Trends, Growth Factors and Opportunities
4.4.4 PVDF Membranes: Geographic Segmentation Analysis
4.5 Nylon Membranes
4.5.1 Introduction and Market Overview
4.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.5.3 Key Market Trends, Growth Factors and Opportunities
4.5.4 Nylon Membranes: Geographic Segmentation Analysis
4.6 Others
4.6.1 Introduction and Market Overview
4.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
4.6.3 Key Market Trends, Growth Factors and Opportunities
4.6.4 Others: Geographic Segmentation Analysis
Chapter 5: Transdermal Drug Delivery Systems Market by Application
5.1 Transdermal Drug Delivery Systems Market Snapshot and Growth Engine
5.2 Transdermal Drug Delivery Systems Market Overview
5.3 Protein Transfer
5.3.1 Introduction and Market Overview
5.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.3.3 Key Market Trends, Growth Factors and Opportunities
5.3.4 Protein Transfer: Geographic Segmentation Analysis
5.4 Nucleic Acid Transfer
5.4.1 Introduction and Market Overview
5.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
5.4.3 Key Market Trends, Growth Factors and Opportunities
5.4.4 Nucleic Acid Transfer: Geographic Segmentation Analysis
Chapter 6: Transdermal Drug Delivery Systems Market by End User
6.1 Transdermal Drug Delivery Systems Market Snapshot and Growth Engine
6.2 Transdermal Drug Delivery Systems Market Overview
6.3 Academic and Research Institutions
6.3.1 Introduction and Market Overview
6.3.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.3.3 Key Market Trends, Growth Factors and Opportunities
6.3.4 Academic and Research Institutions: Geographic Segmentation Analysis
6.4 Pharmaceutical and Biotech Companies
6.4.1 Introduction and Market Overview
6.4.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.4.3 Key Market Trends, Growth Factors and Opportunities
6.4.4 Pharmaceutical and Biotech Companies: Geographic Segmentation Analysis
6.5 Diagnostic Laboratories
6.5.1 Introduction and Market Overview
6.5.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.5.3 Key Market Trends, Growth Factors and Opportunities
6.5.4 Diagnostic Laboratories: Geographic Segmentation Analysis
6.6 Others
6.6.1 Introduction and Market Overview
6.6.2 Historic and Forecasted Market Size in Value USD and Volume Units (2017-2032F)
6.6.3 Key Market Trends, Growth Factors and Opportunities
6.6.4 Others: Geographic Segmentation Analysis
Chapter 7: Company Profiles and Competitive Analysis
7.1 Competitive Landscape
7.1.1 Competitive Benchmarking
7.1.2 Transdermal Drug Delivery Systems Market Share by Manufacturer (2023)
7.1.3 Industry BCG Matrix
7.1.4 Heat Map Analysis
7.1.5 Mergers and Acquisitions
7.2 NOVARTIS AG (SWITZERLAND)
7.2.1 Company Overview
7.2.2 Key Executives
7.2.3 Company Snapshot
7.2.4 Role of the Company in the Market
7.2.5 Sustainability and Social Responsibility
7.2.6 Operating Business Segments
7.2.7 Product Portfolio
7.2.8 Business Performance
7.2.9 Key Strategic Moves and Recent Developments
7.2.10 SWOT Analysis
7.3 JOHNSON & JOHNSON (USA)
7.4 MYLAN N.V. (USA)
7.5 GLAXOSMITHKLINE PLC (UK)
7.6 BAYER AG (GERMANY)
7.7 HISAMITSU PHARMACEUTICAL CO. INC. (JAPAN)
7.8 BOEHRINGER INGELHEIM (GERMANY)
7.9 TEVA PHARMACEUTICAL INDUSTRIES LTD. (ISRAEL)
7.10 3M HEALTHCARE (USA)
7.11 LUYE PHARMA GROUP (CHINA)
7.12 OTHER ACTIVE PLAYERS
Chapter 8: Global Transdermal Drug Delivery Systems Market By Region
8.1 Overview
8.2. North America Transdermal Drug Delivery Systems Market
8.2.1 Key Market Trends, Growth Factors and Opportunities
8.2.2 Top Key Companies
8.2.3 Historic and Forecasted Market Size by Segments
8.2.4 Historic and Forecasted Market Size By Type
8.2.4.1 Nitrocellulose Membranes
8.2.4.2 PVDF Membranes
8.2.4.3 Nylon Membranes
8.2.4.4 Others
8.2.5 Historic and Forecasted Market Size By Application
8.2.5.1 Protein Transfer
8.2.5.2 Nucleic Acid Transfer
8.2.6 Historic and Forecasted Market Size By End User
8.2.6.1 Academic and Research Institutions
8.2.6.2 Pharmaceutical and Biotech Companies
8.2.6.3 Diagnostic Laboratories
8.2.6.4 Others
8.2.7 Historic and Forecast Market Size by Country
8.2.7.1 US
8.2.7.2 Canada
8.2.7.3 Mexico
8.3. Eastern Europe Transdermal Drug Delivery Systems Market
8.3.1 Key Market Trends, Growth Factors and Opportunities
8.3.2 Top Key Companies
8.3.3 Historic and Forecasted Market Size by Segments
8.3.4 Historic and Forecasted Market Size By Type
8.3.4.1 Nitrocellulose Membranes
8.3.4.2 PVDF Membranes
8.3.4.3 Nylon Membranes
8.3.4.4 Others
8.3.5 Historic and Forecasted Market Size By Application
8.3.5.1 Protein Transfer
8.3.5.2 Nucleic Acid Transfer
8.3.6 Historic and Forecasted Market Size By End User
8.3.6.1 Academic and Research Institutions
8.3.6.2 Pharmaceutical and Biotech Companies
8.3.6.3 Diagnostic Laboratories
8.3.6.4 Others
8.3.7 Historic and Forecast Market Size by Country
8.3.7.1 Russia
8.3.7.2 Bulgaria
8.3.7.3 The Czech Republic
8.3.7.4 Hungary
8.3.7.5 Poland
8.3.7.6 Romania
8.3.7.7 Rest of Eastern Europe
8.4. Western Europe Transdermal Drug Delivery Systems Market
8.4.1 Key Market Trends, Growth Factors and Opportunities
8.4.2 Top Key Companies
8.4.3 Historic and Forecasted Market Size by Segments
8.4.4 Historic and Forecasted Market Size By Type
8.4.4.1 Nitrocellulose Membranes
8.4.4.2 PVDF Membranes
8.4.4.3 Nylon Membranes
8.4.4.4 Others
8.4.5 Historic and Forecasted Market Size By Application
8.4.5.1 Protein Transfer
8.4.5.2 Nucleic Acid Transfer
8.4.6 Historic and Forecasted Market Size By End User
8.4.6.1 Academic and Research Institutions
8.4.6.2 Pharmaceutical and Biotech Companies
8.4.6.3 Diagnostic Laboratories
8.4.6.4 Others
8.4.7 Historic and Forecast Market Size by Country
8.4.7.1 Germany
8.4.7.2 UK
8.4.7.3 France
8.4.7.4 The Netherlands
8.4.7.5 Italy
8.4.7.6 Spain
8.4.7.7 Rest of Western Europe
8.5. Asia Pacific Transdermal Drug Delivery Systems Market
8.5.1 Key Market Trends, Growth Factors and Opportunities
8.5.2 Top Key Companies
8.5.3 Historic and Forecasted Market Size by Segments
8.5.4 Historic and Forecasted Market Size By Type
8.5.4.1 Nitrocellulose Membranes
8.5.4.2 PVDF Membranes
8.5.4.3 Nylon Membranes
8.5.4.4 Others
8.5.5 Historic and Forecasted Market Size By Application
8.5.5.1 Protein Transfer
8.5.5.2 Nucleic Acid Transfer
8.5.6 Historic and Forecasted Market Size By End User
8.5.6.1 Academic and Research Institutions
8.5.6.2 Pharmaceutical and Biotech Companies
8.5.6.3 Diagnostic Laboratories
8.5.6.4 Others
8.5.7 Historic and Forecast Market Size by Country
8.5.7.1 China
8.5.7.2 India
8.5.7.3 Japan
8.5.7.4 South Korea
8.5.7.5 Malaysia
8.5.7.6 Thailand
8.5.7.7 Vietnam
8.5.7.8 The Philippines
8.5.7.9 Australia
8.5.7.10 New Zealand
8.5.7.11 Rest of APAC
8.6. Middle East & Africa Transdermal Drug Delivery Systems Market
8.6.1 Key Market Trends, Growth Factors and Opportunities
8.6.2 Top Key Companies
8.6.3 Historic and Forecasted Market Size by Segments
8.6.4 Historic and Forecasted Market Size By Type
8.6.4.1 Nitrocellulose Membranes
8.6.4.2 PVDF Membranes
8.6.4.3 Nylon Membranes
8.6.4.4 Others
8.6.5 Historic and Forecasted Market Size By Application
8.6.5.1 Protein Transfer
8.6.5.2 Nucleic Acid Transfer
8.6.6 Historic and Forecasted Market Size By End User
8.6.6.1 Academic and Research Institutions
8.6.6.2 Pharmaceutical and Biotech Companies
8.6.6.3 Diagnostic Laboratories
8.6.6.4 Others
8.6.7 Historic and Forecast Market Size by Country
8.6.7.1 Turkiye
8.6.7.2 Bahrain
8.6.7.3 Kuwait
8.6.7.4 Saudi Arabia
8.6.7.5 Qatar
8.6.7.6 UAE
8.6.7.7 Israel
8.6.7.8 South Africa
8.7. South America Transdermal Drug Delivery Systems Market
8.7.1 Key Market Trends, Growth Factors and Opportunities
8.7.2 Top Key Companies
8.7.3 Historic and Forecasted Market Size by Segments
8.7.4 Historic and Forecasted Market Size By Type
8.7.4.1 Nitrocellulose Membranes
8.7.4.2 PVDF Membranes
8.7.4.3 Nylon Membranes
8.7.4.4 Others
8.7.5 Historic and Forecasted Market Size By Application
8.7.5.1 Protein Transfer
8.7.5.2 Nucleic Acid Transfer
8.7.6 Historic and Forecasted Market Size By End User
8.7.6.1 Academic and Research Institutions
8.7.6.2 Pharmaceutical and Biotech Companies
8.7.6.3 Diagnostic Laboratories
8.7.6.4 Others
8.7.7 Historic and Forecast Market Size by Country
8.7.7.1 Brazil
8.7.7.2 Argentina
8.7.7.3 Rest of SA
Chapter 9 Analyst Viewpoint and Conclusion
9.1 Recommendations and Concluding Analysis
9.2 Potential Market Strategies
Chapter 10 Research Methodology
10.1 Research Process
10.2 Primary Research
10.3 Secondary Research
Q1: What would be the forecast period in the Transdermal Drug Delivery Systems Market research report?
A1: The forecast period in the Transdermal Drug Delivery Systems Market research report is 2024-2032.
Q2: Who are the key players in the Transdermal Drug Delivery Systems Market?
A2: Novartis AG (Switzerland), Johnson & Johnson (USA), Mylan N.V. (USA), GlaxoSmithKline plc (UK), Bayer AG (Germany), Hisamitsu Pharmaceutical Co., Inc. (Japan), Boehringer Ingelheim (Germany), Teva Pharmaceutical Industries Ltd. (Israel), 3M Healthcare (USA), Luye Pharma Group (China). and Other Active Players.
Q3: What are the segments of the Transdermal Drug Delivery Systems Market?
A3: The Transdermal Drug Delivery Systems Market is segmented into Type, Technology, Application, End User and region. by Type (Passive Transdermal Delivery Systems, Active Transdermal Delivery Systems.), Technology (Iontophoresis, Sonophoresis, Electroporation, Thermal Ablation, Microneedles, Others.), Application (Pain Management, Central Nervous System Disorders, Hormonal Disorders, Cardiovascular Disorders, Others), End User (Hospitals, Home Care Settings, Others). By region, it is analyzed across North America (U.S., Canada, Mexico), Eastern Europe (Russia, Bulgaria, The Czech Republic, Hungary, Poland, Romania, Rest of Eastern Europe), Western Europe (Germany, UK, France, The Netherlands, Italy, Spain, Rest of Western Europe), Asia Pacific (China, India, Japan, South Korea, Malaysia, Thailand, Vietnam, The Philippines, Australia, New-Zealand, Rest of APAC), Middle East & Africa (Turkiye, Bahrain, Kuwait, Saudi Arabia, Qatar, UAE, Israel, South Africa), South America (Brazil, Argentina, Rest of SA).
Q4: What is the Transdermal Drug Delivery Systems Market?
A4: Transdermal drug delivery systems refers to techniques and devices that help administer certain drugs via the outer layer of skin and directly into blood system bypassing the entire gastrointestinal system and regional blood circulation. Such systems are popular since they help to keep plasma drug concentrations constant, increase patients‘ compliance, and decrease GI adverse effects.
Q5: How big is the Transdermal Drug Delivery Systems Market?
A5: Transdermal Drug Delivery Systems Market Size Was Valued at USD 33.60 Billion in 2023, and is Projected to Reach USD 53.93 Billion by 2032, Growing at a CAGR of 5.40% From 2024-2032.
How to Buy a Report from eminsights.jp
On the product page, choose the license you want: Single-User License, Multi-User License or Enterprise License.
If you required report in your native language, then you can click on Translated Report button and fill out the form with report name and language you want, then our team will contact you as soon as possible.
Click the Buy Now button.
You will be redirected to the checkout page. Enter your company details and payment information.
Click Place Order to complete the purchase.
Confirmation: You’ll receive an order confirmation and our team will contact you shortly with your ordered report.
If you have any questions, fill out the contact form below or email us at bizdev@eminsights.net.
Thank you for choosing eminsights.jp!
